A Case of Hand-Foot Syndrome with Pustules and Paronychia Induced by Sunitinib / 대한피부과학회지
Korean Journal of Dermatology
;
: 1384-1386, 2008.
Artigo
em Coreano
| WPRIM
| ID: wpr-142348
ABSTRACT
In January 2006, Sunitinib was approved by the US Food and Drug Administration for the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumor. Sunitinib inhibits the receptor tyrosine kinases that are involved with various receptors whose functions are related to tumor growth, angiogenesis and metastatic progression. The cutaneous adverse reactions of hand-foot syndrome associated with sunitinib are well known, but there have been no previous reports on these reactions in the Korean medical literature. We report here on a case of hand-foot syndrome due to this drug, and we discuss the possible mechanism of hand-foot syndrome caused by sunitinib.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Paroniquia
/
Fosfotransferases
/
Pirróis
/
Tirosina
/
United States Food and Drug Administration
/
Carcinoma de Células Renais
/
Tumores do Estroma Gastrointestinal
/
Síndrome Mão-Pé
/
Indóis
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS